Form 4: Cigna Group Executive Nicole S. Jones Reports Stock Transactions
SEC Form 4
Nicole S. Jones, EVP, Chief Administrative Officer and General Counsel of Cigna Group, reports multiple transactions involving Cigna common stock, including acquisitions, disposals, and shares held in a 401(k) plan.
Summary
- On February 28, 2025, Nicole S. Jones acquired 9,064 shares of Cigna common stock related to the settlement of strategic performance shares.
- An additional 3,147 restricted shares were acquired, vesting in equal annual installments starting March 1, 2026.
- 949 and 4,160 shares were disposed of to cover tax obligations related to vesting of restricted shares and settlement of strategic performance shares, respectively, at a price of $305.86 per share.
- On March 3, 2025, 4,904 shares were sold at $308.12 per share under a Rule 10b5-1 trading plan.
- As of the report, Jones directly owns 29,421 shares and indirectly owns 1,406.3086 shares through a 401(k) plan.
- Jones also acquired 11,176 employee stock options with an exercise price of $305.855, vesting in equal annual installments beginning March 1, 2026, and expiring on February 28, 2035.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are routine and expected as part of executive compensation and portfolio management. There are no clear positive or negative signals.
Positives
- Acquisition of shares through strategic performance shares indicates achievement of company performance goals.
- Grant of restricted shares and stock options suggests continued alignment of executive incentives with shareholder value.
Negatives
- Disposal of shares to cover tax obligations reduces Jones' direct holdings.
- Sale of shares under a 10b5-1 plan, while routine, could be interpreted negatively if the market is sensitive.
Risks
- Market reaction to the sale of shares, even under a pre-arranged plan, could be negative.
- Future tax obligations related to vesting shares could lead to further disposals.
Future Outlook
The executive's holdings will change over time due to vesting of restricted shares and stock options, as well as ongoing participation in the 401(k) plan.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's view of the company's prospects.
Comparison to Industry Standards
- Executive compensation packages at companies like UnitedHealth Group (UNH) and Anthem (now Elevance Health) (ELV) also include stock options and restricted stock units to align executive incentives with shareholder value.
- The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to avoid accusations of insider trading.
Stakeholder Impact
- Shareholders may be interested in the executive's transactions as an indicator of confidence in the company.
- Employees may view the executive's stock ownership as a sign of alignment with their interests.
Next Steps
- Continued monitoring of executive stock transactions for further insights into management's perspective.
- Tracking the vesting of restricted shares and exercise of stock options.
Key Dates
| Date | Description |
|---|---|
| January 10, 2025 | Date of Power of Attorney |
| February 28, 2025 | Date of multiple transactions: acquisition of common stock, restricted shares, and disposal of shares for tax obligations. |
| March 1, 2026 | First vesting date for restricted shares and stock options. |
| March 3, 2025 | Sale of shares under Rule 10b5-1 trading plan. |
| February 28, 2035 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.